Portfolia’s FemTech II Fund has invested in xCures, the AI-powered platform that transforms multiple sources of medical data for patients and doctors evaluating cancer care. Nearly 40% of Americans will face a cancer diagnosis in their lifetime. Understanding a diagnosis and choosing a treatment plan can be overwhelming for patients. With xCures’ AI engine, patients and oncologists can cross reference vast amounts of research and therapies to make informed treatment choices for each unique diagnosis.
top of page
Search
Recent Posts
See AllBy: Steven Loeb Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times...
Matterworks, Inc., developers of the world's most powerful metabolomics platform, which accelerates the discovery, development, and...
Luna, the leading provider of in-home physical therapy, has teamed up with UCI Health, to expand access to patient care by providing...
bottom of page
Comments